.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Medtronic
UBS
Chinese Patent Office
Citi
US Army
Deloitte
Mallinckrodt
Fish and Richardson
Argus Health

Generated: June 28, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; lisinopril - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; lisinopril and what is the scope of hydrochlorothiazide; lisinopril freedom to operate?

Hydrochlorothiazide; lisinopril
is the generic ingredient in three branded drugs marketed by Aurobindo, Sun Pharm Inds Ltd, Lupin, Mylan, Sandoz, Prinston Inc, Invagen Pharms, Hikma Intl Pharms, Teva, Apotex Inc, Ivax Sub Teva Pharms, Merck, Alvogen Malta, and Watson Labs, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; lisinopril. Forty-three suppliers are listed for this compound.

Summary for Generic Name: hydrochlorothiazide; lisinopril

Tradenames:3
Patents:1
Applicants:14
NDAs:15
Drug Master File Entries: see list31
Suppliers / Packagers: see list43
Clinical Trials: see list381
Drug Prices:see low prices
DailyMed Link:hydrochlorothiazide; lisinopril at DailyMed

Pharmacology for Ingredient: hydrochlorothiazide; lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
LISINOPRIL AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL075776-002Jul 1, 2002ABRXNoNo► Subscribe► Subscribe
Sandoz
LISINOPRIL AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL076262-002Jul 1, 2002ABRXNoNo► Subscribe► Subscribe
Watson Labs
LISINOPRIL AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL076194-001Jul 1, 2002ABRXNoNo► Subscribe► Subscribe
Hikma Intl Pharms
LISINOPRIL AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL076265-001Jul 8, 2002ABRXNoNo► Subscribe► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-002Feb 16, 1989DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-001Feb 16, 19894,472,380► Subscribe
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-002Jul 20, 19894,374,829*PED► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-002Feb 16, 19894,472,380► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-003Nov 18, 19934,374,829*PED► Subscribe
Merck
PRINZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL019778-001Feb 16, 19894,374,829*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Citi
Johnson and Johnson
Novartis
Chubb
Cantor Fitzgerald
UBS
McKesson
Healthtrust
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot